Wednesday, Nov 18, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | India | Bharat Biotechs Covaxin 81 Pc Efficient In Phase 3 Clinical Trials

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 clinical trials

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

By PTI
Updated On - 4 March 2021, 12:33 AM
Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 clinical trials
File Photo
whatsapp facebook twitter telegram

New Delhi: Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.


“Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants,”

Bharat Biotech Chairman and Managing Director Krishna Ella said.

Covaxin demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants, he added.

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Covaxin and Oxford-AstraZeneca’s Covishield are the two vaccines that are being administered in the country.

 


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Bharat Biotech
  • Covaxin
  • Indian Council of Medical Research
  • Phase 3 clinical trials

Related News

  • Bharat Biotech announces 40 pc price cut for Mosqivac malaria vaccine

    Bharat Biotech announces 40 pc price cut for Mosqivac malaria vaccine

  • Why a heart attack in Hyderabad is a direct ticket to poverty

    Why a heart attack in Hyderabad is a direct ticket to poverty

  • Pandorum teams up with Bharat Biotech subsidiary

    Pandorum teams up with Bharat Biotech subsidiary

  • ‘Oil and sugar boards’ now coming up at all govt offices, hospitals, public spaces and more

    ‘Oil and sugar boards’ now coming up at all govt offices, hospitals, public spaces and more

Latest News

  • Cherry blossoms turn Sikkim’s Temi Tea Garden into a pink paradise

    2 minutes ago
  • U19 Asia Cup: Mohit Ulva’s last-ball four is a moment Yashbardhan Chauhan will never forget

    2 minutes ago
  • Man allegedly tied up and set ablaze on Bengaluru road in broad daylight

    49 minutes ago
  • Apple restores most services after internal software update triggers outage; rules out cyberattack

    1 hour ago
  • Microsoft unveils AI models, Copilot platform and Azure upgrades at Ignite

    1 hour ago
  • KTR launches ‘Game Changers’ book chronicling journeys of 20 everyday heroes

    2 hours ago
  • Chip curbs, mineral supplies test Trump’s China diplomacy ahead of Xi talks

    2 hours ago
  • Dhanush thanks Dhoni after CSK exit as player, says game will never be the same

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App